By whatever criterion one uses- loss of life, loss of productivity, family disintegration, mental anguish, health care costs, costs at all levels of government- cocaine abuse has posed a significant problem. Adding further to the dimension of this problem is the birth of """"""""crack"""""""" cocaine babies and the AIDS scourge. The cost of this multifaceted problem to this nation, in human and economic terms, is almost beyond comprehension. One particularly important characteristic of drug dependence, regardless of substance, is the pattern of multiple drug use. A consequence of that practice is the potential for interactions among the abused substances which can further exacerbate a toxic state or affect the dependence liability of any or all of the abused substances. In the case of cocaine, what is particularly remarkable is the degree of ethanol coingestion. Several surveys have indicated a high incidence of co-use of these two drugs. It is also clear that this coingestion results in increased pharmacologic response and it results in far greater risk of death compared to cocaine use alone. The reason(s) for these observations has not been firmly established but at least two possibilities exist to explain the ethanol-enhanced response to cocaine. The first involves the alteration in the disposition of cocaine per se and, in concert with this, is the alteration of the profile of active or toxic metabolites. One particularly interesting aspect of the latter possibility is the recent recognition of the formation of an active metabolite, cocaethylene (ethyl cocaine), resulting from the interaction between ethanol and cocaine. The research program outlined here has been designed to quantitate the disposition kinetics of cocaine in the absence and presence of ethanol. This will be done in rats under acute and chronic dosing paradigms. In addition, we propose to examine the response (locomotor activity) to cocaine and metabolites in the absence and presence of ethanol. These data will be used to develop a combined pharmacokinetic-pharmacodynamic model to explore the cocaine-ethanol interaction.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA008094-02
Application #
2120572
Study Section
Drug Abuse Biomedical Research Review Committee (DABR)
Project Start
1993-09-01
Project End
1996-07-31
Budget Start
1994-09-01
Budget End
1995-07-31
Support Year
2
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Arizona
Department
Other Health Professions
Type
Schools of Pharmacy
DUNS #
City
Tucson
State
AZ
Country
United States
Zip Code
85721
Kakkar, T; Pak, Y; Mayersohn, M (2000) Evaluation of a minimal experimental design for determination of enzyme kinetic parameters and inhibition mechanism. J Pharmacol Exp Ther 293:861-9
Kakkar, T; Boxenbaum, H; Mayersohn, M (1999) Estimation of Ki in a competitive enzyme-inhibition model: comparisons among three methods of data analysis. Drug Metab Dispos 27:756-62
Chow, H H; Khor, S P; Lee, H C et al. (1998) A modified equilibrium dialysis technique for measuring plasma protein binding: experimental evaluation with diazepam and nortriptyline. Pharm Res 15:1643-6
Bourland, J A; Martin, D K; Mayersohn, M (1998) In vitro transesterification of cocaethylene (ethylcocaine) in the presence of ethanol. esterase-mediated ethyl ester exchange esterase-mediated ethyl ester exchange. Drug Metab Dispos 26:203-6
Kakkar, T; Mayersohn, M (1998) Simultaneous quantitative analysis of methyl salicylate, ethyl salicylate and salicylic acid from biological fluids using gas chromatography-mass spectrometry. J Chromatogr B Biomed Sci Appl 718:69-75
Tannenbaum, S; Boxenbaum, H; Mayersohn, M (1997) Allometric analysis of organ extraction ratios. J Pharm Sci 86:1319-20
Bourland, J A; Martin, D K; Mayersohn, M (1997) Carboxylesterase-mediated transesterification of meperidine (Demerol) and methylphenidate (Ritalin) in the presence of [2H6]ethanol: preliminary in vitro findings using a rat liver preparation. J Pharm Sci 86:1494-6
Hutchaleelaha, A; Sukbuntherng, J; Mayersohn, M (1997) Simple apparatus for serial blood sampling in rodents permitting simultaneous measurement of locomotor activity as illustrated with cocaine. J Pharmacol Toxicol Methods 37:9-14
Hutchaleelaha, A; Chow, H H; Mayersohn, M (1997) Comparative pharmacokinetics and interspecies scaling of amphotericin B in several mammalian species. J Pharm Pharmacol 49:178-83
Sukbuntherng, J; Martin, D K; Pak, Y et al. (1996) Characterization of the properties of cocaine in blood: blood clearance, blood to plasma ratio, and plasma protein binding. J Pharm Sci 85:567-71

Showing the most recent 10 out of 11 publications